文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

凝血调节蛋白α治疗脓毒症诱导的弥散性血管内凝血的最佳血浆浓度

OPTIMAL PLASMA CONCENTRATION OF THROMBOMODULIN ALFA TO TREAT SEPSIS-INDUCED DISSEMINATED INTRAVASCULAR COAGULATION.
PubMed 文献 · Shock · 2023-06-22
一句话结论脓毒症DIC患者凝血调节蛋白α血浆谷浓度≥1,010 ng/mL与90天生存率显著提高相关(91.7% vs 63.4%,P=0.017)。

本研究测定脓毒症合并DIC患者凝血调节蛋白α(TM alfa)的血浆谷浓度,并用受试者工作特征曲线计算影响治疗结局的截断值。截断值为1,010时,曲线下面积为0.669(95%CI 0.530-0.808),敏感度0.458、特异度0.882。按截断值分组比较,高于截断值组90天生存率显著高于低于截断值组(91.7% vs 63.4%,P=0.017),风险比0.199(95%CI 0.045-0.871)。两组出血性不良事件发生率无显著差异。作者据此推荐脓毒症DIC治疗中TM alfa血浆谷浓度为1,010 ng/mL。

要点

  • 截断值1,010时ROC曲线下面积0.669(95%CI 0.530-0.808),敏感度0.458、特异度0.882。
  • 高于截断值组90天生存率91.7%,低于截断值组63.4%(P=0.017)。
  • 高于截断值组风险比0.199(95%CI 0.045-0.871)。
  • 两组出血性不良事件发生率无显著差异。
  • 作者推荐脓毒症DIC患者TM alfa血浆谷浓度为1,010 ng/mL。

适用人群与场景

  • 脓毒症合并弥散性血管内凝血(DIC)的患者。

诊断标准与关键阈值

  • 以血浆TM alfa谷浓度1,010为截断值,高于或低于该值分组;该截断值用于影响治疗结局的判定。

研究设计与关键结果

  • 研究测定脓毒症DIC患者的TM alfa血浆谷浓度,并用受试者工作特征曲线计算影响治疗结局的截断值。
  • 截断值1,010时,曲线下面积0.669(95%CI 0.530-0.808),敏感度0.458,特异度0.882。
  • 高于截断值组90天生存率91.7%,低于截断值组63.4%,差异显著(P=0.017),风险比0.199(95%CI 0.045-0.871)。
  • 两组出血性不良事件发生率无显著差异。

证据类型、等级与局限

  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者推荐脓毒症DIC治疗中TM alfa血浆谷浓度为1,010 ng/mL,以在最大化疗效的同时最小化严重出血风险。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Thrombomodulin alfa (TM alfa) has been shown effective for treatment of disseminated intravascular coagulation (DIC) associated with sepsis, although the optimal therapeutic plasma concentration has not been clarified. In the present study, the plasma trough concentration of TM alfa in septic patients with DIC was determined, then the cutoff value for that concentration showing influence on treatment outcome was calculated using a receiver operating characteristic curve. With a cutoff value of 1,010, the area under the curve of the receiver operating characteristic was 0.669 (95% confidence interval, 0.530-0.808), with sensitivity of 0.458 and specificity of 0.882. To evaluate its accuracy, patients were divided into those above or below the cutoff value, and 90-day survival rates were compared. The above-cutoff group showed a significantly higher 90-day survival rate (91.7%) as compared with the below-cutoff group (63.4%) ( P = 0.017), with a hazard ratio of 0.199 (95% confidence interval, 0.045-0.871). Interestingly, the incidence of hemorrhagic adverse effects was not significantly different between the groups. Based on these results, the recommended plasma trough concentration of TM alfa for treatment of septic DIC is 1,010 ng/mL, which should minimize the risk of severe bleeding while maximizing the therapeutic effect.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Imaura M, Katagiri F, Nagase S, et al. OPTIMAL PLASMA CONCENTRATION OF THROMBOMODULIN ALFA TO TREAT SEPSIS-INDUCED DISSEMINATED INTRAVASCULAR COAGULATION. Shock. 2023. PMID: 37342874. doi:10.1097/SHK.0000000000002172

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。